Background: Colorectal Cancer (CRC) is one of the most common fatal diseases with high morbidity. Alteration of glucose metabolism is one of the hallmarks in the development of CRC. Glucose Transporter 1 (GLUT1) is a key rate-limiting protein in hyperactive glucose metabolism and up-regulated in CRC, however, the underlying mechanism of the altered metabolism in CRC is still unknown.
Methods: In this study, immunohistochemical staining was used to evaluate the expression of GLUT1 and FOXM1 in 135 paired CRC and adjacent normal tissues. The association between the expression of GLUT1/FOXM1 and clinicopathological factors was determined and the correlation between GLUT1 and FOXM1 in CRC was investigated.
Results: Our results revealed that regardless of tumor location, GLUT1 and FOXM1 were overexpressed in CRC tissues, especially in patients with positive lymph node metastasis and TNM stage III-IV. Furthermore, GLUT1 showed a significantly strong link with FOXM1 in CRC tissue.
Conclusion: Overexpression of GLUT1 and FOXM1 may play critical roles in CRC leading to a poor prognosis.
[http://dx.doi.org/10.18632/oncotarget.15171] [PMID: 28187435]
[http://dx.doi.org/10.1016/B978-0-12-407190-2.00016-2] [PMID: 23870513]
[http://dx.doi.org/10.1038/onc.2010.41] [PMID: 20190804]
[http://dx.doi.org/10.18632/oncotarget.10103] [PMID: 27351131]
[http://dx.doi.org/10.1186/s12885-017-3284-7] [PMID: 28446149]
[http://dx.doi.org/10.18632/oncotarget.18090] [PMID: 28915636]
[http://dx.doi.org/10.1002/jcb.26399] [PMID: 28884839]
[http://dx.doi.org/10.1371/journal.pone.0209937] [PMID: 30735528]
[http://dx.doi.org/10.1371/journal.pone.0170490] [PMID: 28125642]
[http://dx.doi.org/10.1002/hep.24736] [PMID: 21993994]
[http://dx.doi.org/10.1016/j.acthis.2012.01.002] [PMID: 22326401]